Check out your Company Bowl for anonymous work chats.
The life science group Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic.
Sartorius Stedim Biotech has committed $1.5 million to Penn State to create the Sartorius Cell Culture Facility. It is slated to open in the first quarter of 2021 on the University Park campus. Read more:
From the United States, to China, to Sweden – Sartorius’ Key Account Management teams are where their customers are. Collaborating across cultural and language borders as well as time zones is part of their daily work routine. Three colleagues share their tips on international teamwork here:
Sartorius Partners With RoosterBio to Advance Cell and Gene Therapy Manufacturing
Sartorius to acquire Novasep's chromatography process equipment division
Sartorius supports pharmaceutical training in Tanzania
Sartorius acquired U.S.-based filtration expert WaterSep BioSeparations LLC. WaterSep develops, manufactures and markets hollow-fiber membrane devices and pre-sterilized assemblies for upstream and downstream biopharmaceutical applications.
Sartorius and Evotec partner with start-up Curexsys on iPSC-based therapeutic exosome approach:
Sartorius will pay a total of around ten million euros in coronavirus bonuses to its employees in appreciation of their extraordinary commitment and special achievements
